Inventor

BRANDHUBER BARBARA J

US31 patents

⚠️ This page may combine multiple inventors who share the name “BRANDHUBER BARBARA J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRANDHUBER BARBARA J

ARRAY BIOPHARMA INC

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

N-pyrrolidinyl,N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain

Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain

N-bicyclic aryl,N&#39;-pyrazolyl urea, thiourea, guanidine cyanoguanidine compounds as TrkA kinase inhibitors

Methods of treatment using pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds

N-(arylalkyl)-N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors

Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors

Method of structure-based drug design to create or improve modulators of IL-1 activity which bind to the interleukin-1 type 1 receptor

Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors

Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors

Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors

Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trkA kinase inhibitors

N-(monocyclic aryl),N&#39;-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors

LOXO ONCOLOGY INC

Point mutations in TRK inhibitor-resistant cancer and methods relating to the same

Point mutations in TRK inhibitor-resistant cancer and methods relating to the same

Point mutations in TRK inhibitor-resistant cancer and methods relating to the same

Point mutations in TRK inhibitor-resistant cancer and methods relating to the same

Point mutations in TRK inhibitor-resistant cancer and methods relating to the same

Spray-dried dispersions, formulations, and polymorphs of (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide

Spray-dried dispersions, formulations, and polymorphs of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide

N-bicyclic aryl,N'-pyrazolyl urea, thiourea, guanidine cyanoguanidine compounds as TrkA kinase inhibitors

N-(monocyclic aryl),N'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors